Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression

Philip A. Beer, David J. H. F. Knapp, Paul H. Miller, Nagarajan Kannan, Ivan Sloma, Kathy Heel, Sonja Babovic, Elizabeth Bulaeva, Gabrielle Rabu, Jefferson Terry, Brian J. Druker, Marc M. Loriaux, Keith R. Loeb, Jerald P. Radich, Wendy N. Erber, Connie J. Eaves

Blood (2015) 125 (3): 504–515.

https://doi.org/10.1182/blood-2014-06-581173

Published: 2015

Includes: Supplemental data

Journal Articles

Prior Granulocyte Colony-Stimulating Factor Treatment Enhances the Immediate and Transient Output of Primitive Hematopoietic Cells in the Blood of Normal Adult Human Donors Treated with Plerixafor

Paul H. Miller, Naoto Nakamichi, MDPhD, Gabrielle Rabu, Kirk R. Schultz, MD, David M. Jones, MD, Stephen Couban, MD FRCPC, Connie J. Eaves, PhD

Blood (2014) 124 (21): 5787.

https://doi.org/10.1182/blood.V124.21.5787.5787

Published: 2014

Journal Articles

Longterm Multilineage Human Hematopoietic Repopulation of Untreated KIT-Mutant Immunodeficient Mice

Paul H. Miller, Gabrielle Rabu, David J.H.F. Knapp, Alice M.S. Cheung, PhD, Kiran Dhillon, Philip A. Beer, MRCP, FRCPath, PhD, Connie J. Eaves, PhD

Blood (2014) 124 (21): 2415.

https://doi.org/10.1182/blood.V124.21.2415.2415

Published: 2014

Journal Articles

Disruption Of Ikaros In Patients’ Chronic Phase CML Cells Induces The Features Of Accelerated Phase Disease

Philip A Beer, MRCP, FRCPath, PhD, Ivan Sloma, PhD, Paul H Miller, BAppSc, David JHF Knapp, BSc, Gabrielle Rabu, BSc, Connie J Eaves, PhD

Blood (2013) 122 (21): 513.

https://doi.org/10.1182/blood.V122.21.513.513

Published: 2013

Journal Articles

Enhanced normal short-term human myelopoiesis in mice engineered to express human-specific myeloid growth factors

Paul H. Miller, Alice M. S. Cheung, Philip A. Beer, David J. H. F. Knapp, Kiran Dhillon, Gabrielle Rabu, Shabnam Rostamirad, R. Keith Humphries, Connie J. Eaves

Blood (2013) 121 (5): e1–e4.

https://doi.org/10.1182/blood-2012-09-456566

Published: 2013

Includes: Supplemental data

NARROW

Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression

Prior Granulocyte Colony-Stimulating Factor Treatment Enhances the Immediate and Transient Output of Primitive Hematopoietic Cells in the Blood of Normal Adult Human Donors Treated with Plerixafor

Longterm Multilineage Human Hematopoietic Repopulation of Untreated KIT-Mutant Immunodeficient Mice

Disruption Of Ikaros In Patients’ Chronic Phase CML Cells Induces The Features Of Accelerated Phase Disease

Enhanced normal short-term human myelopoiesis in mice engineered to express human-specific myeloid growth factors

Email alerts

ASH Publications

American Society of Hematology

Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression

Prior Granulocyte Colony-Stimulating Factor Treatment Enhances the Immediate and Transient Output of Primitive Hematopoietic Cells in the Blood of Normal Adult Human Donors Treated with Plerixafor

Longterm Multilineage Human Hematopoietic Repopulation of Untreated KIT-Mutant Immunodeficient Mice

Disruption Of Ikaros In Patients’ Chronic Phase CML Cells Induces The Features Of Accelerated Phase Disease

Enhanced normal short-term human myelopoiesis in mice engineered to express human-specific myeloid growth factors

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only